ijms-logo

Journal Browser

Journal Browser

Intron Retention (IR): RNA Processing, Post-Transcriptional Regulation in Stress Response, Genomic Function

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Genetics and Genomics".

Deadline for manuscript submissions: 30 November 2026 | Viewed by 1097

Special Issue Editor


E-Mail Website
Guest Editor
Laboratory of Genomics for Health and Longevity, School of Pharmacy, Kitasato University, Tokyo 108-8641, Japan
Interests: mechanism and application of intron retention

Special Issue Information

Dear Colleagues,

Intron retention (IR) has emerged as a prevalent and regulated mode of RNA processing rather than a mere splicing byproduct. Across diverse stress conditions—oxidative, genotoxic, inflammatory, metabolic, proteotoxic, hypoxic, and mechanical—IR can reshape gene output by modulating nuclear detention, mRNA stability, translation competence, and the balance between productive and non-productive isoforms. Increasing evidence links stress-responsive IR programs to cell-fate decisions, immune adaptation, tissue regeneration, aging, and disease, including cancer, neurodegeneration, cardiometabolic disorders, and infection.

This Special Issue welcomes original research, reviews, and methodological advances that elucidate mechanisms, functions, and translational implications of IR. We particularly encourage studies integrating multi-omics and modern transcriptomics (long-read sequencing, single-cell/spatial approaches), quantitative modeling, and rigorous computational frameworks for IR detection and interpretation. This Special Issue will cover a wide range of research topics, such as the following:

  • Mechanistic control of IR under stress: co-transcriptional splicing kinetics, Pol II elongation, chromatin/epigenetic coupling, and spliceosome dynamics.
  • Neuropsychiatric and neurodegenerative applications: IR-based biomarkers for depression and dementia, including patient stratification and treatment-response monitoring.
  • Stress signaling to splicing: ISR/ATF4, MAPK, mTOR, NF-κB, and post-translational regulation of splicing factors/RBPs.
  • IR as an RNA output gate: nuclear detention/export licensing, RNA surveillance (NMD), mRNA stability, and translation competence.
  • Cis–trans logic of IR: regulatory elements, RNA structure, and SR/hnRNP networks shaping IR propensity and specificity.
  • Subcellular RNA fate programs: stress granules/P-bodies, phase separation, and translational reprogramming in acute vs chronic stress.
  • Proteostasis, redox, and metabolism: coupling of IR to UPS/ER stress, mitochondrial function, oxidative stress, and metabolic remodeling.
  • Genome maintenance links: IR responses to DNA damage/replication stress and consequences for cell-cycle and genome stability.
  • Mechanobiology and IR: cytoskeletal tension, focal-adhesion pathways, nuclear lamina mechanics, and mechanotransduction impacts on RNA processing.
  • Immune context: IR programs in thymus/spleen/lymph nodes and immune-state transitions (tolerance, inflammation, immunometabolism).

Dr. Norihiro Okada
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • intron retention
  • alternative splicing
  • RNA processing
  • stress response
  • post-transcriptional regulation
  • nuclear export
  • nonsense-mediated decay
  • RNA surveillance
  • RNA-binding proteins
  • long-read sequencing
  • single-cell transcriptomics
  • biomarker
  • systems biology
  • disease mechanisms
  • proteostasis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

21 pages, 4428 KB  
Review
Intron Retention as a Homeostatic State Variable for Drug Response and Recovery: Lessons from Depression for Broader Applications
by Norihiro Okada, Kenshiro Oshima, Akiko Maruko, Akinori Nishi and Yoshinori Kobayashi
Int. J. Mol. Sci. 2026, 27(8), 3539; https://doi.org/10.3390/ijms27083539 - 16 Apr 2026
Viewed by 682
Abstract
Clinically robust molecular biomarkers for depression have remained elusive, despite extensive transcriptomic research. This gap is consequential: depression is prevalent and heterogeneous, yet objective measures to quantify burden, stratify patients, and track recovery remain limited. Here, we review evidence that intron retention (IR) [...] Read more.
Clinically robust molecular biomarkers for depression have remained elusive, despite extensive transcriptomic research. This gap is consequential: depression is prevalent and heterogeneous, yet objective measures to quantify burden, stratify patients, and track recovery remain limited. Here, we review evidence that intron retention (IR) can serve as a homeostatic state variable—and therefore a sensitive biomarker—reporting stress adaptation and recovery at an upstream regulatory layer, often preceding or outperforming differential gene expression (DEG) readouts. Mechanistically, IR enables bidirectional fine-tuning of effective gene output: increased IR (IncIR) can throttle output under overload, whereas decreased IR (DecIR) releases this brake to restore gene output. Because these shifts are reversible and treatment-responsive, IR signatures can function not only as disease markers but also as pharmacodynamic metrics for blood-based monitoring of drug response and recovery. To evaluate the clinical utility of IR, we use depression as a proof of concept and focus on two interventions: (i) the Kampo formula hangekobokuto (HKT), which is associated with IR normalization consistent with reduced peripheral inflammatory load; and (ii) ketamine, where IR patterns measured before ketamine treatment in non-responders are linked to stronger innate-immune/antiviral activity, suggesting a higher inflammatory load that may limit treatment benefit. Finally, we discuss transdiagnostic extensions beyond depression, using early cognitive decline (mild cognitive impairment, MCI) as a stringent, biologically distal test case for blood-based IR/DI readouts and motivating independent cohort replication and longitudinal validation. Full article
Show Figures

Figure 1

Back to TopTop